JUPITER NEUROSCIENCES, INC. COMMON STOCK (NASDAQ: JUNS)

NASDAQ: JUNS (Jupiter Neurosciences, Inc.)

最近更新时间: 3天之前, 10:45AM

-0.05 (-3.87%)

加入群组

预期市盈率 (P/E Forward)	20.33
股市价格/股市净资产 (P/B)	731.49

52周波幅

0.510 (-57%) — 19.51 (1536%)

市场趋势

AIStockmoo 评分

-0.9

相关股票

股票	市值	DY	P/E（TTM）	P/B
JUNS	41 M	-	-	731.49
LEGN	5 B	-	-	5.06
MAZE	2 B	-	-	4.82
RAPP	1 B	-	-	2.77
ELVN	1 B	-	-	2.56
JBIO	570 M	-	-	-

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
部门	Healthcare
行业	Biotechnology
内部持股比例	57.50%
机构持股比例	1.17%

所有权

姓名	日期	持有股份
Vestor Capital, Llc	30 Sep 2025	970,985

该时间范围内无数据。

日期	类型	细节
03 Dec 2025	公告	Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum
02 Dec 2025	公告	Jupiter Neurosciences to Participate in NobleCon21
06 Nov 2025	公告	Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
05 Nov 2025	公告	Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
27 Oct 2025	公告	Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
15 Sep 2025	公告	Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador

支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

没有符合您标准的股票